The Future of Triple Therapy in chronic obstructive pulmonary disease
Arch Bronconeumol (Engl Ed). 2018 Feb;54(2):63-64.
doi: 10.1016/j.arbres.2017.06.019.
Epub 2017 Jul 29.
[Article in
English,
Spanish]
Affiliations
- 1 AIG de Medicina, Hospital de Alta Resolución de Loja, Agencia Sanitaria Hospital de Poniente, Loja, Granada, España; Departamento de Medicina, Facultad de Medicina, Universidad de Granada, Granada, España. Electronic address: balcazar@telefonica.net.
- 2 AIG de Medicina, Hospital de Alta Resolución de Loja, Agencia Sanitaria Hospital de Poniente, Loja, Granada, España.
- 3 Departamento de Medicina, Facultad de Medicina, Universidad de Granada, Granada, España.
No abstract available
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use*
-
Adrenergic beta-2 Receptor Agonists / therapeutic use*
-
Drug Therapy, Combination / methods
-
Drug Therapy, Combination / trends
-
Forecasting
-
Humans
-
Muscarinic Antagonists / therapeutic use*
-
Pulmonary Disease, Chronic Obstructive / drug therapy*
-
Randomized Controlled Trials as Topic
Substances
-
Adrenal Cortex Hormones
-
Adrenergic beta-2 Receptor Agonists
-
Muscarinic Antagonists